Epinephrine
Epinephrine nasal spray outcomes comparable with injections among pediatric patients
WASHINGTON — An epinephrine nasal spray resulted in outcomes that were comparable with injections in pediatric patients, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
Top in allergy/asthma: COVID-19 vaccine reactions; Racial disparities in food allergies
Most people who reported a reaction to a COVID-19 vaccine said they were unlikely to receive another vaccine in the future, according to a survey from Massachusetts General Hospital.
ARS Pharma continues epinephrine nasal spray studies while awaiting FDA approval
ARS Pharma continues to study the effectiveness and safety of its neffy epinephrine nasal spray as patients with allergies wait for an alternative to autoinjectors for anaphylaxis treatment.
Q&A: Joint task force updates anaphylaxis practice parameter
A joint task force has published an updated, evidence-based practice parameter for diagnosing and treating anaphylaxis in Annals of Allergy, Asthma & Immunology.
Top in allergy/asthma: Phone screen protector triggers allergy; Q&A on Flovent generics
After a woman developed a rash on her face and fingers several times, her doctors discovered the cause was her cell phone, specifically the acrylate screen protector on her cell phone.
Hospital type, region significant predictors for observation time following anaphylaxis
Most EDs do not have specific guidelines for observation time following anaphylaxis, and the average duration depends largely on comorbidities and the type of hospital, according to a survey study.
Q&A: Epinephrine nasal spray may overcome autoinjector limitations
An intranasal epinephrine spray produced pharmacokinetic and pharmacodynamic results that were comparable or superior to intramuscular injections, according to a study published in The Journal of Allergy and Clinical Immunology: Global.
Nasal epinephrine spray outcomes comparable with autoinjector, manual injections
An intranasal epinephrine spray produced pharmacokinetic and pharmacodynamic results that were comparable or superior to intramuscular injections, according to a study published in The Journal of Allergy and Clinical Immunology: Global.
VIDEO: FDA-requested study of epinephrine nasal spray underway
ANAHEIM, Calif. — ARS Pharma is conducting an additional clinical trial of its neffy epinephrine nasal spray per FDA request, company cofounder, president and CEO Richard Lowenthal, MS, MSEL, told Healio.
Joint task force releases anaphylaxis, atopic dermatitis treatment parameters
Two new practice parameters from a joint task force published in Annals of Allergy, Asthma & Immunology provide evidence-based recommendations for the diagnosis and management of anaphylaxis and atopic dermatitis.